Proscia
Pathology AI. #1 Best in KLAS. Enterprise-grade intelligence for the decisions that matter most.
Pathology AI. #1 Best in KLAS. Enterprise-grade intelligence for the decisions that matter most.
Published Sep 20, 2026
This research did not uncover an obvious, comprehensive product listing for Proscia/Concentriq on mainstream SaaS review platforms such as G2 or Capterra. As a result, procurement teams should prioritize reference checks and peer validation rather than relying solely on public review platforms.
Public employee reviews show mixed sentiment about organizational factors such as pace of change and work-life balance. These comments reflect internal organizational factors that can affect vendor operations and support, but they do not directly measure product quality or customer experience in deployments.
Common buyer drivers cited across vendor materials and industry sources include:
Potential reasons for not selecting or for replacing the product include:
Vendor materials describe a feasibility study with a large diagnostic laboratory that indicated increased case throughput when AI-assisted workflows were used.
Critical evaluation: Reported throughput improvements should be evaluated in the context of study design, case mix, baseline workflow, study duration, and potential learning curve effects. Buyers should request study protocols and performance metrics related to diagnostic quality and rework.
Proscia has published high-level metrics related to volumes diagnosed on the platform and year-over-year increases in press materials.
Critical evaluation: These headline metrics do not include methodology. Buyers should ask for clarification on definitions (for example: whether counts are per patient, per case, per slide, or per event) and whether duplicates or non-primary diagnosis events are excluded.
Get a comprehensive analysis of Proscia including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →When a procuring organization requires a single-vendor turnkey ecosystem (scanner, IMS, storage, and service) with minimal integration work.
When procurement demands publicly posted security attestations (e.g., SOC 2 or ISO 27001) in public materials as a gating requirement.
When transparent, self-serve pricing with predictable, low variability is required.
When the organization has highly bespoke LIS workflows and very limited internal IT capacity for integration and testing.
When the primary requirement is specialized image analysis rather than enterprise IMS and workflow management.
The most accessible customer sentiment in public materials is vendor-published testimonials and commissioned summaries. These are useful for directional insight but are curated by the vendor and not an independent sample.
Independent summaries (for example, analyst spotlight excerpts shared on vendor pages) indicate positive outcomes in referenced interviews; the full independent reports were not available through the public vendor landing pages reviewed.
Proscia announced FDA 510(k) clearance for Concentriq AP-Dx. The vendor described a multi-site study and reported a non-inferiority result versus glass reads with a small difference in major discordance rates.
Critical evaluation: The clearance indicates the vendor provided sufficient evidence for the cleared indications and specified conditions of use. Procurement should review the FDA documentation, including indications for use and any scanner or workflow pairings noted in the clearance, to confirm alignment with the buyer's intended environment.
Proscia offers an enterprise digital pathology software platform, Concentriq®, designed to manage, view, collaborate on, and apply artificial intelligence (AI) to whole-slide images (WSI) for clinical diagnostics and life sciences research and development (R&D). The platform is intended to integrate scanners, laboratory information systems (LIS), AI applications, and teams, and is available in cloud and on-premises deployment models.
Concentriq comprises three product variants:
Proscia targets two overlapping customer groups:
Vendor positioning signals emphasize suitability for high-throughput, multi-site laboratories, support for multiple scanner models and formats, integration with AI applications, and availability of cloud-hosted deployments.